#metastatic cancer

The checkpoint inhibitor is now approved for people with advanced non-small-cell lung cancer regardless of PD-L1 biomarker levels.

Study results support the need for research into the value of monitoring these breast cancer patients with brain imaging tests.

Metastatic colorectal cancer is on the rise among those under 50. Doctors must not dismiss young people who come to them with symptoms.

Cancer mortality was about 3.5% lower in states that expanded Medicaid.

Daniel Zeller, who blogs about his prostate cancer experiences, shares study findings that could be relevant to other cancers.

Is DNA fate? Are cell mutations really the cause of cancer? A Fred Hutch skin cancer and stem cell scientist poses other possibilities.

The combination of target drugs Tafinlar-Mekinist is approved for nearly any type of advanced solid tumor that has the BRAF gene mutation.

The clinical trial was offered to her as an equal – and potentially better – option to FDA approved treatments and surgery.

Researchers discovered that breast cancer tumors “wake up when patients are sleeping.”

Researchers observed a trend of increased risk of major financial hardship in younger, non-white, lower-income patients.

Defining one of cancer’s most common and intimidating terms

A small Spanish study suggests that screening people living with HIV for lung cancer results in a high rate of diagnosis.

Erin Cronican, who has metastatic breast cancer, stars in a new production of Wit, a play about a woman dying of metastatic ovarian cancer.

Episode 20 with Daniel P. Petrylak, MD, Professor of Medicine (Medical Oncology) and of Urology

A look at the symptoms, treatments, risk factors, prognosis and research on breast cancer metastasis to the brain.

Immunotherapy was far more effective than targeted therapy in extending survival for people with certain kinds of advanced melanoma.